‘Cash is king’ in a crisis

Accountants tell us that turnover is vanity, profit is sanity, but cash is king. This is so true in a crisis and even more so...

Novartis, US drug regulator agree to malaria drug trial to fight Covid-19

Novartis has won the go-ahead from the US Food and Drug Administration to conduct a randomized trial of malaria drug hydroxychloroquine against Covid-19 disease, the...

Boots partners with LIVI to strengthen its digital pharmacy services

Boots UK on Thursday (16) announced a new partnership with digital healthcare provider LIVI to strengthen its digital pharmacy services. The existing Boots UK and LIVI...

Officials urged to treat all frontline clinicians equally

By Simon Dukes Chief Executive Pharmaceutical Services Negotiating Committee FOR me, the genuine privilege of being the negotiator for community pharmacy in England is meeting and talking...

India might produce Covid-19 vaccine for the world: Cipla Boss

By Amit Roy INDIAN businessman Yusuf Hamied believes that a vaccine for coronavirus will be tested on humans in six months, and when it does...

Michelle Riddalls is PAGB’s new chief executive

The consumer healthcare association PAGB has appointed Michelle Riddalls as its new chief executive. Riddalls succeeds John Smith, who has led Proprietary Association of Great...

Clenil Modulite 100mcg may run out of stock

Pharmaceutical giant Chiesi today said its Clenil Modulite 100 microgram pressurised metered dose inhalers are expected to face intermittent supply problems over the next...

EMIS Group acquires PharmOutcomes operators

EMIS Group has acquired Pinnacle Health Partnership and Pinnacle Systems Management– owners and operators of the PharmOutcomes platform. The acquisition aims to drive widespread improvements...

Investment in pharmacist training delivers benefits for people living with asthma, COPD

For many thousands of people living with long term conditions, the quality of care they receive from healthcare professionals can have a significant impact...

Sanofi reintroduces original formulation Syndol tablets

Sanofi on Wednesday announced the return of original formulation Syndol tablets, which is used for headache and migraine relief, after five years of absence. The...